Biotech innovation is no longer concentrated in a handful of established hubs. Across the U.S., regions like Oklahoma City, Las Vegas, and Central Pennsylvania are demonstrating how strategic investment, cross-sector partnerships, and specialized expertise can accelerate life sciences innovation and strengthen domestic biomanufacturing.
As Oklahoma City’s first large-scale CDMO, we’re proud to be mentioned and see our hometown recognized by BioPharma Dive as an emerging biotech hub. Together with our partners across industry, academia, and government, we’re helping expand the region’s biomanufacturing capabilities and creating new opportunities for innovators developing the next generation of biologic therapies.
As Oklahoma City’s first large-scale CDMO, we’re proud to be mentioned and see our hometown recognized by BioPharma Dive as an emerging biotech hub. Together with our partners across industry, academia, and government, we’re helping expand the region’s biomanufacturing capabilities and creating new opportunities for innovators developing the next generation of biologic therapies.
The future of biopharma will be shaped by a diverse network of innovation ecosystems, and Oklahoma City’s continued growth is leading the way.
Read the full article here